The sell-side on Wall Steet is predicting Evoke Pharma, Inc. (NASDAQ:EVOK) to grow at an accelerated rate over the next five years. Sell-side analysts are looking for the company to grow 79.30% over the next year and 40.00% over the next five years.
EPS measures what each share is worth and also indicates how much money their sharehoders would gain if the company was to pay out all of its profits. Evoke Pharma, Inc.’s trailing 12- months EPS is -0.89. Last year, their EPS growth was 38.40% and their EPS growth over the past five years was 12.00%.
Let’s start off by taking a look at how the stock has been performing recently. Over the past twelve months, Evoke Pharma, Inc. (NASDAQ:EVOK)’s stock was 39.11%. Last week, it was 2.93%, 19.57% over the last quarter, and 6.84% for the past half-year.
Over the past 50 days, Evoke Pharma, Inc. stock was -32.03% off of the high and 10.32% removed from the low. Their 52-Week High and Low are noted here. -38.90% (High), 95.77%, (Low).
Evoke Pharma, Inc. (NASDAQ:EVOK)’s performance this year to date is 39.11%. The stock has performed 2.93% over the last seven days, -26.25% over the last thirty, and 19.57% over the last three months. Over the last six months, Evoke Pharma, Inc.’s stock has been 6.84% and 68.26% for the year.
FUTURE GROWTH ESTIMATES AND RECOMMENDATIONS
Wall Street analysts are have a consensus analyst recommendation of 2.00 on the stock. This is based on a 1-5 scale where 1 represents a Strong Buy and 5 a Strong Sell. Brokerages covering the name have a $8.40 on the stock.
The advice provided on this website is general advice only. It has been prepared without taking into account your objectives, financial situation or needs. Before acting on this advice you should consider the appropriateness of the advice, having regard to your own objectives, financial situation and needs. Where quoted, past performance is not indicative of future performance.